Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy.

Abstract

Thirty-two stage IC or stage I grade 3 patients with invasive ovarian adenocarcinoma were treated with 6 months of adjuvant cisplatin-based chemotherapy. With a median follow-up of 60.5 months, there have been three (9%) recurrences. The 5-year progression-free survival was 90.5% and the 5-year survival was 93.3%.

Cite this paper

@article{Piver1992FiveyearSF, title={Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy.}, author={M. Steven Piver and John H . Malfetano and Trenton R Baker and Ronald E. Hempling}, journal={Gynecologic oncology}, year={1992}, volume={46 3}, pages={357-60} }